ESW Tearcheck® (by E-Swin France) is an advanced, non-invasive diagnostic device that performs 9 automated ocular surface tests in under 10 minutes. It evaluates tear break-up time (TFSE®/NIBUT), ocular surface inflammation (OSIE®), meibomian gland loss (Meibo-Check®), tear meniscus height (TMH), blink completeness, and Demodex infestation to map the exact root cause of your dry eyes.

IRPL® (Intense Regulated Pulsed Light - E-Eye) is a patented French medical technology specifically designed for ophthalmology and Meibomian Gland Dysfunction (MGD). Unlike generic dermatological IPL, IRPL delivers precisely sculpted, cooled light sub-pulses that stimulate the parasympathetic nervous system innervating the Meibomian glands, prompting them to resume natural secretion of healthy tear-protecting lipids.

The clinically validated protocol consists of 3 to 4 quick outpatient sessions: Session 1 (Day 1), Session 2 (Day 15), Session 3 (Day 45), and an optional Session 4 (Day 75) for severe cases. Each session takes only 5 to 10 minutes, is completely painless, and requires zero downtime.

MGD is the leading cause of dry eye disease (over 85% of cases). The microscopic oil glands in your eyelids become blocked or inflamed, depriving your tear film of its protective lipid layer and causing your tears to evaporate within seconds.

Common symptoms include burning, stinging, gritty feeling (like sand in the eye), redness, excessive watering (reflex tearing), light sensitivity, and fluctuating blurred vision during computer or screen work.

When your cornea dries out due to rapid tear evaporation, corneal nerves send emergency reflex signals prompting the lacrimal glands to flood the eye with watery tears. However, these lack lubricating oils and evaporate quickly, creating a vicious cycle of irritation.

Artificial tears only offer temporary, short-term moisture without treating blocked meibomian glands or surface inflammation. Clinical therapies like ESW Tearcheck diagnostic mapping, IRPL® therapy, and punctal plugs treat the root cause for lasting relief.

Yes, IRPL® is completely non-invasive and FDA/CE certified for ophthalmic use. Protective eye shields are worn during the procedure. Patients feel only a gentle, warm sensation on the cheekbone and lower eyelid area, with no pain or downtime.

Clinical studies demonstrate that completing the 3-session IRPL protocol restores tear film stability and provides significant symptom relief for 6 to 12+ months. Many patients only require an occasional single maintenance session once a year.

Yes. Blinking frequency drops by over 60% during computer and smartphone usage, and many blinks become incomplete. Combined with air-conditioned environments, this accelerates tear evaporation. Our ESW Tearcheck specifically measures your blink completeness to guide ergonomic adjustments.